{
  "ticker": "T3D",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973183",
  "id": "02973183",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250728",
  "time": "0930",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6c3880x6lgr.pdf",
  "summary": "### **Appendix 4C & Quarterly Report Summary**  \n\n- **Cash Receipts from Customers**: $275,234 (12.09% increase QoQ).  \n- **Net Operating Cash Flow**: **($85)** (vs. $23,012 cash received last quarter).  \n- **New Contracts**: Two healthcare contracts secured post-trial, generating **$970k+ revenue** over past year.  \n- **Closing Cash Balance**: **$75,263** (down from $75,346 last quarter).  \n- **Related-Party Payments**: $12,042 (reimbursement to directors).  \n- **Quarterly Expenditure**: $275,342 (breakdown: $140k operations, $24k staff, $111k admin).  \n\n**No material subsequent events** or capital-raising activity disclosed.  \n\n---  \n*Note: No material valuation impacts identified beyond revenue growth and cash position.*",
  "usage": {
    "prompt_tokens": 3782,
    "completion_tokens": 190,
    "total_tokens": 3972,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-27T23:38:16.523409"
}